BCL9L and neoplasm: To confirm the involvement of BCL9L in matrix stiffness-induced tumor stemness, we knocked down BCL9L in LN229/T98G cells using short hairpin RNA (shRNA) technology (Supplementary Figure 1B) and overexpressed BCL9L in LN229/T98G cells (Supplementary Figure 1C).